Skip to main content
TERUMO CORPORATION logo

TERUMO CORPORATION — Investor Relations & Filings

Ticker · 4543 ISIN · JP3546800008 LEI · 353800JX1R4582QVK932 SGX Manufacturing
Open in API
Filings indexed 89 across all filing types
Latest filing 2018-12-25 Regulatory Filings
Country JP Japan
Listing SGX 4543

About TERUMO CORPORATION

https://www.terumo.co.jp/

Terumo Corporation is a global medical technology company that develops, manufactures, and markets a broad portfolio of medical devices, equipment, and solutions. Its core business activities are centered on several key areas: Cardiac and Vascular, Blood and Cell Technologies, and Hospital and Pharmaceutical Solutions. The Cardiac and Vascular business provides products for interventional procedures, neurovascular therapies, and cardiovascular surgery. The Blood and Cell Technologies division offers solutions for blood transfusion, apheresis, and cell therapy processing. The company also supplies general hospital products, including infusion systems and medical disposables, alongside life care products for consumers and specialized pharmaceutical solutions that integrate drugs with delivery devices.

Recent filings

Filing Released Lang Actions
訂正有価証券報告書－第103期(平成29年4月1日－平成30年3月31日)
Regulatory Filings
2018-12-25 Japanese
四半期報告書－第104期第2四半期(2018/07/01－2018/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Terumo Corporation, covering the second quarter of the fiscal year ending March 31, 2019. It contains detailed financial statements, management analysis (MDA), and corporate information as required by the Financial Instruments and Exchange Act of Japan. Since it is a comprehensive financial report for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report (IR). H1 2019
2018-11-12 Japanese
四半期報告書－第104期第1四半期(2018/04/01－2018/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Terumo Corporation, covering the first quarter of the 104th fiscal period (April 1, 2018, to June 30, 2018). It contains detailed financial statements, management analysis (MDA), and audit review information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2019
2018-08-13 Japanese
有価証券報告書－第103期(平成29年4月1日－平成30年3月31日)
Annual Report
2018-06-25 Japanese
四半期報告書－第103期第3四半期(2017/10/01－2017/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Terumo Corporation, covering the third quarter of the 103rd fiscal period (April 1, 2017, to December 31, 2017). It contains detailed financial statements, including the consolidated balance sheet, income statement, and comprehensive income statement, as well as management analysis. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data for a period shorter than a full fiscal year. 9M 2018
2018-02-13 Japanese
四半期報告書－第103期第2四半期(2017/07/01－2017/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Terumo Corporation, covering the second quarter of the 103rd fiscal period (April 1, 2017 to September 30, 2017). It contains detailed financial statements, management analysis of financial conditions, and operational results, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2018
2017-11-13 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.